scispace - formally typeset
D

Danijela Krstić

Researcher at University of Belgrade

Publications -  62
Citations -  2858

Danijela Krstić is an academic researcher from University of Belgrade. The author has contributed to research in topics: Na+/K+-ATPase & Homocysteine. The author has an hindex of 18, co-authored 59 publications receiving 2171 citations. Previous affiliations of Danijela Krstić include Yahoo!.

Papers
More filters
Journal ArticleDOI

Acetylcholinesterase Inhibitors: Pharmacology and Toxicology

TL;DR: An overview of toxicology and pharmacology of reversible and irreversible acetylcholinesterase inactivating compounds is presented, with emphasis on oxime reactivators of the inhibited enzyme activity administering as causal drugs after the poisoning.
Journal ArticleDOI

Targeting the alpha 1 subunit of the sodium pump to combat glioblastoma cells.

TL;DR: In this paper, the effects of inhibiting Na+/K+-ATPase alpha 1 in human GBM cells with respect to cell proliferation; morphology; impact on intracellular Na+, Ca2+, and adenosine triphosphate; and changes in the actin cytoskeleton were investigated.
Journal ArticleDOI

Toxic effects of diazinon and its photodegradation products.

TL;DR: Although after 15-min diazinon irradiation formed products do not affect purified commercial enzymes activities, inhibitory effect of irradiated solutions on cell enzymes increased as a function of time exposure to UV light and resulted in significant reduction of AChE and Na(+)/K(+)-ATPase at the end of irradiation period.
Journal ArticleDOI

Sulphur-containing Amino Acids: Protective Role Against Free Radicals and Heavy Metals.

TL;DR: Sulphur-containing amino acids represent a powerful part of cell antioxidant system and may offer a chelating site for heavy metals as antioxidant agents against free radicals, providing beneficial effects in eliminating toxic metals.
Journal ArticleDOI

Polyoxometalates in Biomedicine: Update and Overview.

TL;DR: Although a wide range of biological activities of polyoxometalates was reported, they are not close to clinical trials and the final application in the treatment of diabetes, infectious and malignant diseases, and biomedical studies should be performed on solution-stable compounds under physiological conditions and concentrations employed.